Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TransPacific Venture Partners (TPV) is a venture capital firm based in Taipei City, Taiwan, established to invest in early-stage medical technology ventures. The firm was founded by a team of partners with extensive backgrounds in medicine, engineering, venture investing, and startup founding. TPV is dedicated to identifying unmet needs in healthcare and supporting the development of innovative products that can significantly impact the industry.
Currently, TPV focuses on the Asian market, particularly in Taiwan, where it operates from its office located at 3F., No.80, Zhouzi St., Neihu Dist., Taipei City 114. The firm maintains reserves for subsequent financing rounds, ensuring that it can support its portfolio companies through various stages of their development. Although specific fund sizes are not disclosed, TPV's investment range typically falls between $500,000 and $3 million.
Notable milestones include the firm's affiliation with Center Lab and Center Ventures, which enhances its access to resources and expertise within the medical technology sector. This strategic relationship positions TPV as a key player in the Asian medical technology landscape.
TransPacific Venture Partners specializes in early-stage investments within the medical technology sector, specifically targeting companies that address unmet healthcare needs. The firm invests between $500,000 and $3 million, focusing on pre-seed, seed, and seed-plus stages. This investment strategy allows TPV to support innovative startups that are developing groundbreaking medical solutions.
TPV's investment thesis emphasizes the importance of identifying gaps in healthcare and supporting ventures that can create significant improvements in patient care and medical outcomes. The firm seeks founders who demonstrate a strong understanding of their market and possess the technical expertise necessary to bring their products to fruition. Additionally, TPV maintains reserves for follow-on investments, which enables it to provide continued support to its portfolio companies as they grow.
Dr. Michelle Lin - Partner. Dr. Lin serves as a mentor in Taiwan's TransMedx Accelerator Program for medical technology startups. She has a strong background in healthcare and is involved in various aspects of venture investing and startup development.
TPV's team is described as comprised exclusively of healthcare executives and practitioners, with expertise in discovery, pre-clinical and clinical development, business development, finance, and executive management across the Pacific Rim. This diverse expertise enhances the firm's ability to support its portfolio companies effectively.
To pitch TransPacific Venture Partners, startups should reach out via email at contact@transpacific-vc.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. Founders should expect a response time that varies based on the volume of inquiries, but prompt and clear communication is encouraged.
Warm introductions can enhance the chances of securing a meeting, as TPV values connections within the medical technology community. Startups should be prepared to discuss their vision and how their product addresses specific healthcare needs during the pitch.
As of March 2026, no specific recent deals or announcements have surfaced regarding TransPacific Venture Partners. The firm continues to actively assess and invest in early-stage medical technology ventures across the Pacific Rim.
What are TransPacific Venture Partners' investment criteria?
TPV focuses on early-stage medical technology companies that address unmet healthcare needs. The firm typically invests between $500,000 and $3 million in pre-seed, seed, and seed-plus stages.
How can startups apply or pitch to TPV?
Startups interested in pitching to TransPacific Venture Partners can reach out via email at contact@transpacific-vc.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes TPV different from other venture capital firms?
TransPacific Venture Partners differentiates itself through its exclusive focus on medical technology and its partners' extensive backgrounds in healthcare and engineering. This expertise allows TPV to provide valuable mentorship and strategic guidance to its portfolio companies.
What is TPV's geographic scope?
TPV primarily invests in the Asian market, with a strong emphasis on Taiwan. The firm is well-positioned to leverage local knowledge and connections within the medical technology ecosystem.
What is TPV's post-investment involvement like?
TPV adds value to its portfolio companies by providing mentorship, strategic guidance, and facilitating connections within the medical technology sector. The firm is actively involved in supporting the growth of its investments.
What is the typical check size for investments?
TransPacific Venture Partners typically invests between $500,000 and $3 million in early-stage medical technology ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.